The N-terminal domain of EBNA1 acts as a suppressor of the HER2/neu oncogene

Cancer Letters

Volumn 273, Issue 2, 2009, Pages 273-280

  Liu, Jah Yao ^a   Chuang, Tzu Chao ^b   Way, Tzong Der ^c   Tsai, Tzung Chieh ^d   Hu, Chih Lin ^e   Liu, Guang Yaw ^f   Wang, Shan Shue ^g   Chung, Jing Gung ^c   Kao, Ming Ching ^c,e  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAMKANG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g KAO YUAN UNIVERSITY   (Taiwan)

Author keywords

Cell cycle; EBNA1; EBV; Gene therapy; HER2 neu

Indexed keywords

BETA ACTIN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1; PACLITAXEL; PROTEIN P185; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENE THERAPY; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; ONCOGENES; OVARIAN NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2;

HUMAN HERPESVIRUS 4;

EID: 57349091705     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.013     Document Type: Article

References (36)

1. Shih C., Padhy L., Murray M., and Weinberg R.A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290 (1981) 261-264
2. Yu D., and Hung M.C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19 (2000) 6115-6121
3. Lee K.F., Simon H., Chen H., Bastes B., Hung M.C., and Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378 (1995) 394-398
4. Yu D., Suen T.C., Yan D., Chang L., and Hung M.C. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc. Natl. Acad. Sci USA 87 (1990) 4499-4503
5. Suen T.C., and Hung M.C. C-myc reverses neu-induced transformed morphology by transcriptional repression. Mol. Cell. Biol. 11 (1991) 354-362
6. Matin A., and Hung M.C. Negative regulation of the neu promoter by the SV40 large T antigen. Cell Growth Different. 4 (1993) 1333-1339
7. Matin A., and Hung M.C. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence. Oncogene 9 (1994) 1-6
8. Mizuguchi G., Kanei-Ishii C., Tokahashi T., Yasulawa T., Nagase T., Horikoshi N., Yamamoto T., and Ishii S. C-Myb repression of c-erbB-2 transcription by direct binding to the c-erbB-2 promoter. J. Biol. Chem. 270 (1995) 9384-9389
9. Matin A., Xie Y., Kao M.C., and Hung M.C. Rodent p53 supresses the transforming activity of the activated neu oncogene by modulating the basal promoter activity of neu. Int. J. Oncol. 6 (1995) 1087-1092
10. Kao M.C., Liu G.Y., Chuang T.C., Lin Y.S., Wuu J.A., and Law S.L. The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene. Oncogene 16 (1998) 547-554
11. Lin Y.C., Peng J.M., and Wang W.B. The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene. Oncogene 19 (2000) 2704-2713
12. Chuang T.C., Way T.D., Lin Y.S., Law S.L., and Kao M.C. The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene. FEBS Lett. 532 (2002) 135-142
13. Yates J.L., Warren N., Reisman D., and Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci USA 81 (1984) 3806-3810
14. Reisman D., and Sugden B. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6 (1986) 3838-3846
15. Lunemann J.D., Edwards N., Muraro P.A., Hayashi S., Cohen J.I., Münz C., and Martin R. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129 (2006) 1493-1506
16. Chittenden T., Lupton S., and Levine A.J. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication. J. Virol. 63 (1989) 3016-3025
17. Hammerschmidt W., and Sugden B. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease. Trends Mol. Med. 10 (2004) 331-336
18. Kang M.S., Lu H., Yasui T., Sharp A., Warren H., Cahir-McFarland E., Bronson R., Hung S.C., and Kieff E. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc. Natl. Acad. Sci USA 102 (2005) 820-825
19. Kang M.S., Soni V., Bronson R., and Kieff E. Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice. J. Virol. 82 (2008) 4180-4183
20. Suen T.C., and Hung M.C. Multiple cis- and trans-acting elements involved in regulation of the neu gene. Mol. Cell. Biol. 10 (1990) 6306-6315
21. Yu D., Suen T.C., Yan D.H., Chang L.S., and Hung M.C. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc. Natl. Acad. Sci USA 87 (1990) 4499-4503
22. Gao X., and Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179 (1991) 280-285
23. Chuang T.C., Yu Y.H., Lin Y.S., Wang S.S., and Kao M.C. The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancers. FEBS Lett. 511 (2002) 46-50
24. Chuang T.C., Lee Y.J., Liu J.Y., Lin Y.S., Li J.W., Wang V., Law S.L., and Kao M.C. EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs. Biochem. Biophys. Res. Commun. 307 (2003) 653-659
25. Yu D., Jing T., Liu B., Yao J., Tan M., McDonnell T.J., and Hung M.C. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol. Cell 2 (1998) 581-591
26. Chen H., and Hung M.C. Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene. J. Biol. Chem. 272 (1997) 6101-6104
27. Eckner R., Ludlow J.W., Lill N.L., Oldread E., Arany Z., Modjtahedi N., DeCaprio J.A., Livingston D.M., and Morgan J.A. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16 (1996) 3454-3464
28. Avantaggiati M.L., Carbone M., Grassmann A., Nakatani Y., Howard B., and Levine A.S. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J. 15 (1996) 2236-2248
29. Rawlins D.R., Milman G., Hayward S.D., and Hayward G.S. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42 (1985) 859-868
30. Snudden D.K., Hearing J., Smith P.R., Grasser F.A., and Griffin B.E. EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J. 13 (1994) 4840-4847
31. Ambinder R.F., Mullen M.A., Chang Y.N., Hayward G.S., and Hayward S.D. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65 (1991) 1466-1478
32. Wu H., Kapoor P., and Frappier L. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J. Virol. 76 (2002) 2480-2490
33. Kennedy G., and Sugden B. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 23 (2003) 6901-6908
34. Nahta R., Yu D., Hung M.C., Hortobagyi G.N., and Esteva F.J. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat. Clin. Pract. Oncol. 3 (2006) 269-280
35. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
36. Shire K., Ceccarelli D.F., Avolio-Hunter T.M., and Frappier L. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 73 (1999) 2587-2595